INTERCURE LTD. Inactive Instrument
InterCure Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
INCR
IL0011063760
Healthcare Facilities & Services
| Sales 2022 | 388.68 1.45K | Sales 2023 | 355.55 1.32K | Capitalization | 211M 786M |
|---|---|---|---|---|---|
| Net income 2022 | 44M 164M | Net income 2023 | -62M -231M | EV / Sales 2022 | 1,473,908 x |
| Net Debt 2022 | 22.37M 83.25M | Net Debt 2023 | 89.71M 334M | EV / Sales 2023 | 845,888 x |
| P/E ratio 2022 |
12.2
x | P/E ratio 2023 |
-3.41
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 64.2% |
More Fundamentals
* Assessed data
More news
Latest transcript on InterCure Ltd.
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 18-09-30 | |
Amos Cohen
DFI | Director of Finance/CFO | 45 | 20-02-29 |
Boaz Lahav
SAM | Sales & Marketing | - | 22-10-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ehud Barak
CHM | Chairman | 81 | 18-08-31 |
| Chief Executive Officer | 53 | 18-09-30 | |
| Director/Board Member | 62 | 20-10-31 |
InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +40.74% | 284M | |
| +32.99% | 270M | |
| +50.58% | 198M | |
| -31.64% | 146M | |
| +56.59% | 142M | |
| -14.29% | 120M | |
| -7.69% | 89.69M | |
| +150.00% | 75.33M | |
| +11.25% | 68.6M |
